Skip to main content

Table 2 Treatment administered during admission and methods recognized by the patients themselves for dyspnea relief prior to hospitalization

From: Degree of dyspnoea at admission and discharge in patients with heart failure and respiratory diseases

  Total N=258 Heart Failure
N=190
Respiratory Disease
N=68
p
Location and treatment administered during admission
 Intensive care unit admission 71 (27.5) 62 (32.6) 9 (13.2) 0.002
 Non-invasive mechanical ventilation 48 (18.6) 31 (16.3) 17 (25.0) 0.11
 Diuretics 216 (83.7) 187 (98.4) 29 (42.6) 0.0001
 Bronchodilators 85 (33.0) 32 (16.8) 53 (77.9) 0.0001
 Benzodiazepines 138 (53.4) 112 (58.9) 26 (38.2) 0.004
 Opioids 41 (15.9) 34 (17.9) 7 (10.3) 0.17
 MEDD (mg) 8.7±0.8 8.0±0.6 12.4±3.3 0.03
 Antidepressants 34 (13.2) 24 (12.6) 10 (14.9) 0.67
Methods used for dyspnoea relief prior to hospitalization
 Sleeping with high headboard 140 (54.3) 115 (60.5) 25 (36.8) 0.001
 Fan 16 (6.2) 15 (7.9) 1 (1.5) 0.03
 Oxygen 46 (17.8) 15 (7.9) 31 (45.6) 0.0001
 Continuous Positive Airway Pressure 24 (9.3) 11 (5.8) 13 (19.1) 0.003
 Inhalers 91 (35.3) 37 (19.5) 54 (79.4) 0.0001
 None 58 (22.5) 51 (26.8) 7 (10.3) 0.003
 Communication with GP regarding dyspnoea 153 (59.3) 98 (51.6) 54 (79.4) 0.0001
 Seeking for medical attention during admission due to acute dyspnoea 96 (37.2) 73 (38.4) 23 (33.8) 0.53
 Thinks that treatment received could be better 91 (35.3) 65 (34.2) 26 (38.2) 0.57
  1. GP General practitioner, MEDD, Morphine Equivalent Daily Dosage
  2. Data are shown as number of patients and (mean±standard deviation for Mean Morphine Equivalent Daily Dosage [MEDD]). Categorical variables are contrasted using the χ2 test and Fisher’s exact test and comparison for MEDD is made using the t test
\